24.08.2010 • News

Evonik to Expand Production Capacities in China

Demand for triacetonamine derivatives (TAA derivatives) has kept rising for several years. Evonik Industries is taking advantage of the economic opportunities afforded by this situation and is considerably expanding its production capacities for these special derivatives in China. The foundations for a new plant will be laid as early as this year.

Currently, Evonik produces the derivatives in a joint venture Evonik Tianda (Liaoyang) Chemical Additive at the Liaoyang site in northeastern China. The existing production capacities are to be moved within the Liaoyang region to the Aromatic Site (LAS), one of the country's largest petrochemical sites. Furthermore, production will be significantly increased. Full production is scheduled to commence in the fourth quarter of 2011.

Virtual Event

CHEManager Spotlight

Digitalization in the Chemical Industry

29 April 2026 | This webinar explores how chemical industry organizations can design a digital‑ and AI‑ready operating model focused on clarity, usability, and measurable value.

From Lab to Market Challenge

Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.